922718-09-0 Usage
Description
(R)-1-cyclopropyl-7-fluoro-9-methyl-8-[3-[1-(methyl-piperidin-4-yl-amino)-cyclopropyl]-pyrrolidin-1-yl]-4-oxo-4H-quinolizine-3-carboxylic acid is a complex organic compound characterized by its quinolizine core structure. It features a fluorine atom, a cyclopropyl group, a methyl group, and a carboxylic acid functional group, along with a piperidine moiety. (R)-1-cyclopropyl-7-fluoro-9-methyl-8-[3-[1-(methyl-piperidin-4-yl-amino)-cyclopropyl]-pyrrolidin-1-yl]-4-oxo-4H-quinolizine-3-carboxylic acid's stereochemistry is designated as (R), which refers to the absolute configuration at a chiral center. Its structural complexity and functional groups suggest potential applications in the pharmaceutical industry, possibly as an antibacterial agent or for other medicinal uses.
Uses
Used in Pharmaceutical Industry:
(R)-1-cyclopropyl-7-fluoro-9-methyl-8-[3-[1-(methyl-piperidin-4-yl-amino)-cyclopropyl]-pyrrolidin-1-yl]-4-oxo-4H-quinolizine-3-carboxylic acid is used as a potential active pharmaceutical ingredient (API) for the development of new drugs. Its unique structure and functional groups may provide it with specific biological activities, such as antibacterial properties or other therapeutic effects.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, this compound can be used as a starting point for the design and synthesis of new drug candidates. Its structural features, including the quinolizine core, fluorine atom, and chiral center, can be exploited to optimize its pharmacological properties and selectivity.
Used in Antibacterial Drug Development:
Given the compound's structural characteristics, it may be used as a potential antibacterial agent. The cyclopropyl group, fluorine atom, and carboxylic acid functional group could contribute to its ability to target and disrupt bacterial cell processes, making it a candidate for further research and development in the fight against antibiotic-resistant infections.
Used in Drug Synthesis and Optimization:
(R)-1-cyclopropyl-7-fluoro-9-methyl-8-[3-[1-(methyl-piperidin-4-yl-amino)-cyclopropyl]-pyrrolidin-1-yl]-4-oxo-4H-quinolizine-3-carboxylic acid's complex structure and functional groups make it a valuable tool in the synthesis of new drugs. Researchers can use this compound as a template to create derivatives with improved pharmacokinetic and pharmacodynamic properties, potentially leading to more effective and safer medications.
Check Digit Verification of cas no
The CAS Registry Mumber 922718-09-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,2,7,1 and 8 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 922718-09:
(8*9)+(7*2)+(6*2)+(5*7)+(4*1)+(3*8)+(2*0)+(1*9)=170
170 % 10 = 0
So 922718-09-0 is a valid CAS Registry Number.
922718-09-0Relevant articles and documents
Development of a Dual-Acting Antibacterial Agent (TNP-2092) for the Treatment of Persistent Bacterial Infections
Ma, Zhenkun,Lynch, Anthony Simon
, p. 6645 - 6657 (2016)
The clinical management of prosthetic joint infections and other persistent bacterial infections represents a major unmet medical need. The rifamycins are one of the most potent antibiotic classes against persistent bacterial infections, but bacteria can
